AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment

BACKGROUND: Aurora kinase A (AurkA) is over-expressed in melanoma and its inhibition has been observed to limit tumor growth, suggesting a potential role in melanoma treatment. METHODS: A human melanoma cell line with the B-RAF (V600E) mutation (A375mel) was exposed to B-RAF inhibitor (GSK2118436),...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Transl Med
Main Authors: Caputo, Emilia, Miceli, Roberta, Motti, Maria Letizia, Taté, Rosarita, Fratangelo, Federica, Botti, Gerardo, Mozzillo, Nicola, Carriero, Maria Vincenza, Cavalcanti, Ernesta, Palmieri, Giuseppe, Ciliberto, Gennaro, Pirozzi, Giuseppe, Ascierto, Paolo Antonio
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2014
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4237855/
https://ncbi.nlm.nih.gov/pubmed/25074438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-014-0216-z
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares